CALL US NOW 0207 939 0780
PLEASE DONATE

Tagged as: hepatitis C

APPG on Haemophilia and Contaminated Blood – Latest Meeting

The APPG on Haemophilia and Contaminated Blood met on the 29th March. The Agenda for the Meeting was: Introductions and Apologies New Contaminated Blood Support consultation Aspects of the new proposals The new scheme administrator Plans for engagement Proposed meeting with Lord O’Shaughnessy Update on actions from the last meeting

Read More

Response to the Contaminated Blood Announcement and Consultation

Overview The Department of Health (DH) today published a written ministerial statement announcing some changes to the support scheme for people affected by contaminated blood and launching a new consultation on the Special Category Mechanism and the discretionary support scheme. The consultation will run for six weeks, until the 17th

Read More

Direct-acting Antiviral (DAA) treatment for Hepatitis C risks Hepatitis B reactivation

New guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) advises that all hepatitis C patients should be screened for hepatitis B before starting treatment with new Direct-acting Antivirals (DAAs). If patients are infected with both viruses this does not preclude treatment but this should be monitored and managed.

Read More